In order to rule out that the observed effects of ACLY KD were more related to its role in tumor cell aggressiveness by inducing acetyl‐CoA‐level‐dependent protein acetylation,[23] we also performed the KD of ACC, the latter representing the enzyme catalyzing the following step in de novo lipogenesis utilizing acetyl‐CoA for fatty acid synthesis. The gene discussed is ACLY; the disease is neoplasm.